Estrogen's potential impact on chemoresistance in high-grade serous ovarian cancer

被引：0
|
作者：
Marolt, N. [1 ]
Pavlic, R. [1 ]
Gjorgoska, M. [1 ]
Kreft, T. [1 ]
Rizner, T. Lanisnik [1 ]
机构：
[1] Univ Ljubljana, Fac Med, SI-1000 Ljubljana, Slovenia
来源：
FEBS OPEN BIO | 2024年 / 14卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P-26-081
引用
收藏
页码：283 / 283
页数：1
相关论文
共 50 条
  • [1] Reversing chemoresistance in high grade serous ovarian cancer
    Saxena, Jayeta
    Nicolini, Francesco
    Lockley, Michelle
    CANCER RESEARCH, 2019, 79 (13)
  • [2] Identification of novel therapeutic targets to overcome chemoresistance in high-grade serous ovarian cancer
    Christie, E.
    Huang, C.
    Zhang, V.
    Cowley, K.
    Simpson, K.
    Wang, G.
    Cao, P.
    Wiedemeyer, W.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S113 - S113
  • [3] The high-grade serous ovarian cancer metastasis and chemoresistance in 3D models
    Tadic, Vanja
    Zhang, Wei
    Brozovic, Anamaria
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (01):
  • [4] Singling out tumor heterogeneity and chemoresistance in high-grade serous ovarian cancer.
    Erkan, Erdogan Pekcan
    Dai, Jun
    Zhang, Kaiyang
    Kaipio, Katja
    Lamminen, Tarja
    Mansuri, Naziha
    Suominen, Lasse
    Alkodsi, Amjad
    Huhtinen, Kaisa
    Hietanen, Sakari
    Hynninen, Johanna
    Grenman, Seija
    Carpen, Olli
    Hautaniemi, Sampsa
    Vaharautio, Anna
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 59 - 59
  • [5] The Potential of Targeting Ribosome Biogenesis in High-Grade Serous Ovarian Cancer
    Yan, Shunfei
    Frank, Daniel
    Son, Jinbae
    Hannan, Katherine M.
    Hannan, Ross D.
    Chan, Keefe T.
    Pearson, Richard B.
    Sanij, Elaine
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (01):
  • [6] 5-Hydroxymethylcytosine signals in serum are a predictor of chemoresistance in high-grade serous ovarian cancer
    Weigert, Melanie
    Cui, Xiao-Long
    West-Szymanski, Diana
    Yu, Xianbin
    Bilecz, Agnes Julia
    Zhang, Zhou
    Dhir, Rohin
    Kehoe, Mia
    Zhang, Wei
    He, Chuan
    Lengyel, Ernst
    GYNECOLOGIC ONCOLOGY, 2024, 182 : 82 - 90
  • [7] Unlocking the potential of organopalladium complexes for high-grade serous ovarian cancer therapy
    Scattolin, Thomas
    Cavarzerani, Enrico
    Alessi, Dario
    Mauceri, Matteo
    Botter, Eleonora
    Tonon, Giovanni
    Caligiuri, Isabella
    Repetto, Ombretta
    Kamensek, Urska
    Brezar, Simona Kranjc
    Dalla Pozza, Maria
    Palazzolo, Stefano
    Cemazar, Maja
    Canzonieri, Vincenzo
    Demitri, Nicola
    Nolan, Steven P.
    Gasser, Gilles
    Visentin, Fabiano
    Rizzolio, Flavio
    DALTON TRANSACTIONS, 2025, 54 (11) : 4685 - 4696
  • [8] Identification of Potential Prognostic Competing Triplets in High-Grade Serous Ovarian Cancer
    Zhao, Jian
    Song, Xiaofeng
    Xu, Tianyi
    Yang, Qichang
    Liu, Jingjing
    Jiang, Bin
    Wu, Jing
    FRONTIERS IN GENETICS, 2021, 11
  • [9] The Changing View of High-Grade Serous Ovarian Cancer
    Berns, Els M. J. J.
    Bowtell, David D.
    CANCER RESEARCH, 2012, 72 (11) : 2701 - 2704
  • [10] The genesis and evolution of high-grade serous ovarian cancer
    Bowtell, David D. L.
    NATURE REVIEWS CANCER, 2010, 10 (11) : 803 - 808
12345